Physician
Angel Medical Group, INC
Angel Medical Group, INC was paid $114K by Medicaid between Sep 2019 and Jun 2021, across 59 billing codes. Its largest line is 97802, — 16% of everything it billed.
33Billing provider infoANGEL MEDICAL GROUP, INC
NEWPORT BEACH, CA 92660
NEWPORT BEACH, CA 92660
33aNPI1982880118assigned 01/17/2008
33bProvider typeFamily Medicine Physician
28Total paid$114K
24GClaims14,339
24DCodes billed59
24AFirst – last monthSep 2019 – Jun 2021
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#575 of 2,511
Median peer was paid$13K
This provider vs. median8.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 104 | $622.56 | |
| 2020 | 7,882 | $67K | |
| 2021 | 6,353 | $47K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97802 | 16% | 842 | 839 | $19K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 12% | 1,074 | 1,012 | $14K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 12% | 238 | 163 | $13K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 12% | 238 | 184 | $13K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.8% | 539 | 500 | $9K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.5% | 292 | 291 | $7K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.9% | 252 | 252 | $7K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.5% | 189 | 189 | $6K |
| 90686 | 3.7% | 456 | 455 | $4K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 2.8% | 227 | 226 | $3K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.8% | 64 | 64 | $2K |
| 96156 | 1.7% | 61 | 61 | $2K |
47 more codes
| 90688 | 1.6% | 245 | $2K | |
| 99199 | Unlisted special service, procedure or report | 1.3% | 34 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.2% | 41 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 141 | $1K |
| 92081 | <1% | 43 | $1K | |
| 90670 | <1% | 96 | $846.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 16 | $814.96 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 79 | $733.32 |
| 90685 | <1% | 68 | $513.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $471.16 |
| 90633 | <1% | 52 | $468.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $446.07 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 103 | $352.83 |
| 90647 | <1% | 41 | $351.00 | |
| 90651 | <1% | 32 | $288.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 13 | $278.76 |
| 80061 | Lipid panel | <1% | 26 | $228.40 |
| 90723 | <1% | 27 | $225.00 | |
| 90680 | <1% | 25 | $207.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 26 | $189.93 |
| 85018 | <1% | 116 | $174.25 | |
| 82947 | <1% | 64 | $173.31 | |
| 83655 | <1% | 29 | $161.74 | |
| 80053 | Comprehensive metabolic panel | <1% | 30 | $137.85 |
| 90734 | <1% | 13 | $117.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13 | $101.40 |
| 90649 | <1% | 13 | $72.00 | |
| 96127 | <1% | 54 | $19.04 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 57 | $0.03 |
| 1036F | 0% | 2,552 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 2,678 | $0.00 |
| 3008F | 0% | 1,698 | $0.00 | |
| 1126F | 0% | 16 | $0.00 | |
| 36416 | 0% | 69 | $0.00 | |
| 3074F | 0% | 33 | $0.00 | |
| 1170F | 0% | 13 | $0.00 | |
| 1160F | 0% | 207 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 460 | $0.00 |
| 1159F | 0% | 206 | $0.00 | |
| 3078F | 0% | 101 | $0.00 | |
| 0502F | 0% | 123 | $0.00 | |
| 4120F | 0% | 31 | $0.00 | |
| 97803 | 0% | 12 | $0.00 | |
| 1033F | 0% | 42 | $0.00 | |
| 99401 | 0% | 61 | $0.00 | |
| 3725F | 0% | 27 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIEMEN, SHERRI (CREDENTIALING/OPERATIONS CONSULTANT)